We use cookies to give you the best experience on our website. By continuing to use the site, you agree to our privacy policy.
Learn More
OK
June 2 - 5, 2026
About
Exhibition
2025 Exhibitors
2025 Pavilions
Floor Plan
Events
Stage Agenda
Stage Program
Speakers
Pitch Contest
Media
News Release
Exhibitor News
Interview
Videos
Photos
Weekly Newsletter
Partners
COMPUTEX
Login
中
2023 Finals
Share
Share
×
 
KAICO LTD.
Japan
Healthcare & Biotech
Funding Stage: N/A
Founding Year: 2018
Looking for
Investors
Partners
Manufacturers
Markets
Promotion
Mentors
Media
Other
Product/Solution
Oral Vaccine, Feed Additive, Antibody Test Kit
Company Description
KAICO creates hard-to-express proteins by using specially bred silkworms. KAICO develop cytokines and enzymes for medicine, diagnostic agent, and reagent with silkworms
Back